Description

Mirabegron (ER) (25mg) and Solifenacin succinate (5mg) MIRAGRON S 25/5 is a highly effective combination medication containing Mirabegron (25 mg) and Solifenacin (5 mg), specifically formulated for the treatment of overactive bladder (OAB). This condition is characterized by frequent urination, urgency, and, in some cases, urinary incontinence. The combination of these two active ingredients provides dual action by relaxing bladder muscles and improving bladder control, offering patients long-lasting relief from OAB symptoms. Mirabegron acts as a β3-adrenoceptor agonist, which helps the bladder relax during the storage phase, thereby increasing its capacity. Solifenacin, on the other hand, is a muscarinic receptor antagonist that works by reducing involuntary bladder contractions. Together, these two components work synergistically to improve bladder function, reduce urinary urgency, and enhance overall quality of life for individuals suffering from OAB. Uses of MIRAGRON S 25/5 MIRAGRON S 25/5 tablets are primarily used in the management and treatment of overactive bladder syndrome (OAB) and related urinary symptoms. The main therapeutic uses include: Treatment of Overactive Bladder (OAB): Helps manage symptoms like frequent urination and urinary urgency. Urinary Incontinence: Reduces involuntary leakage of urine caused by an overactive bladder. Urinary Frequency: Decreases the need to urinate often, especially at night (nocturia). Bladder Muscle Relaxation: Improves bladder storage capacity and reduces bladder spasms. Improvement of Quality of Life: Provides relief from embarrassing and uncomfortable urinary symptoms. By addressing both the storage and contraction issues of the bladder, MIRAGRON S 25/5 offers a comprehensive approach to OAB treatment. Benefits of MIRAGRON S 25/5 Dual Mechanism of Action: Combines Mirabegron and Solifenacin, offering a synergistic effect for better control of bladder function. Enhanced Bladder Capacity: Mirabegron relaxes bladder muscles, allowing more urine to be stored and reducing frequent trips to the bathroom. Reduced Urgency and Frequency: Helps patients manage sudden urges and frequent urination, promoting comfort and confidence in daily activities. Improved Quality of Sleep: Reduces nighttime urination, enabling better rest and sleep quality. Better Symptom Control: Compared to monotherapy, the combination provides superior symptom management for moderate to severe OAB cases. Long-Lasting Relief: Provides sustained symptom control throughout the day, improving bladder stability and control. Convenient Once-Daily Dosing: Easy to administer with a single tablet per day, ensuring better compliance and effective results. Dosage of MIRAGRON S 25/5 Recommended Dose: The usual adult dose is one tablet of MIRAGRON S 25/5 taken once daily. It should be swallowed whole with water and not crushed or chewed. Administration: It can be taken with or without food, ideally at the same time each day for best results. Missed Dose: If a dose is missed, take it as soon as you remember. If it’s almost time for your next dose, skip the missed one and continue as usual. Do not double the dose. Dosage Adjustment: The dosage may vary based on individual response, age, and medical condition. Patients with severe kidney or liver problems may require dose modifications as advised by a healthcare provider. Always follow the prescribing doctor’s guidance for optimal therapeutic outcomes. Side Effects of MIRAGRON S 25/5 Like any medication, MIRAGRON S 25/5 may cause some side effects, although not everyone experiences them. Common and mild side effects include: Dry mouth Constipation Headache Urinary tract infection (UTI) Dizziness Increased heart rate (tachycardia) Nausea Abdominal discomfort Rare but serious side effects may include: Difficulty in urination or urinary retention Severe allergic reactions (rash, itching, swelling) Chest pain or irregular heartbeat Swelling of the face, lips, or throat If any of these symptoms persist or worsen, seek immediate medical attention. Always report unusual reactions to your healthcare provider.